Nalaganje...
Cisplatin/carboplatin cross-resistance in ovarian cancer.
Forty-six patients who were treated with cisplatin or carboplatin for ovarian cancer developed resistant disease (no change in measurable disease or progressive disease) and 'crossed over' to the other platinum compound. Three patients (6.5%) responded to this second treatment but these pa...
Shranjeno v:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Publishing Group
1989
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2247292/ https://ncbi.nlm.nih.gov/pubmed/2803953 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|